Search alternatives:
significant cause » significant change (Expand Search), significant changes (Expand Search), significant gap (Expand Search)
positive decrease » positive breast (Expand Search)
cause decrease » caused decreased (Expand Search), use decreased (Expand Search), causes increased (Expand Search)
Showing 61 - 80 results of 24,779 for search '(( significant cause decrease ) OR ( significant positive decrease ))', query time: 3.18s Refine Results
  1. 61
    M<sup>pro</sup> confers a significant reduction in growth in yeast caused by decreases in a variety of cellular proteins.

    M<sup>pro</sup> confers a significant reduction in growth in yeast caused by decreases in a variety of cellular proteins. by Jin Ou (16914305)

    Published 2023
    Save to List
    Saved in:
  2. 62
    Evogliptin attenuates the pyroptotic cell death of VSMCs during CER treatment by decreasing the pyroptotic-associated genes and GSDM-D cleavage efficiency <i>in-vitro.</i>

    Evogliptin attenuates the pyroptotic cell death of VSMCs during CER treatment by decreasing the pyroptotic-associated genes and GSDM-D cleavage efficiency <i>in-vitro.</i> by Razia Rashid Rahil (22772495)

    Published 2025
    Save to List
    Saved in:
  3. 63
    The conventional and new positions of the anchor points in each part of exosuit.

    The conventional and new positions of the anchor points in each part of exosuit. by Jihun Kim (10091)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  4. 64
    Concentration of RebA and Steviol showed increased significantly, whereas stevioside showed significant decrease in all the transgenic lines.

    Concentration of RebA and Steviol showed increased significantly, whereas stevioside showed significant decrease in all the transgenic lines. by Nazima Nasrullah (6874496)

    Published 2023
    Save to List
    Saved in:
  5. 65
    RSV test results in function of demographics.

    RSV test results in function of demographics. by Reem Eid (20889732)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 66
    Logistic regression for RSV results predictors.

    Logistic regression for RSV results predictors. by Reem Eid (20889732)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 67
    RSV test results (N = 268).

    RSV test results (N = 268). by Reem Eid (20889732)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 68
    CUMS increased the expression of pro-apoptosis factor, but decreased the expression of anti-apoptosis factor, while the combination of CUMS and smoke exacerbated these changes by increasing inflammation and dysfunction of BDNF system in the amygdala.

    CUMS increased the expression of pro-apoptosis factor, but decreased the expression of anti-apoptosis factor, while the combination of CUMS and smoke exacerbated these changes by i... by Bai-Ping Liu (14164799)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  9. 69
    Significant results of the MR analysis.

    Significant results of the MR analysis. by Nikolina Pleić (18858220)

    Published 2024
    Save to List
    Saved in:
  10. 70
    Baseline and post-treatment results of categorical electrocardiographic variables in each study group.

    Baseline and post-treatment results of categorical electrocardiographic variables in each study group. by Káryta Suely Macêdo Martins (22404155)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 71
    Line graph showing the values of inflammatory cytokines at baseline and after treatment.

    Line graph showing the values of inflammatory cytokines at baseline and after treatment. by Káryta Suely Macêdo Martins (22404155)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 72
    Baseline and Post-Treatment Myocardial Perfusion Defects Expressed as a Percentage of the Total Left Ventricular Surface Area in Each Experimental Group.

    Baseline and Post-Treatment Myocardial Perfusion Defects Expressed as a Percentage of the Total Left Ventricular Surface Area in Each Experimental Group. by Káryta Suely Macêdo Martins (22404155)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 73
    Baseline and post-treatment results of quantitative electrocardiographic variables in each study group.

    Baseline and post-treatment results of quantitative electrocardiographic variables in each study group. by Káryta Suely Macêdo Martins (22404155)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 74
    CONSORT diagram illustrating patient flow during the study.

    CONSORT diagram illustrating patient flow during the study. by Káryta Suely Macêdo Martins (22404155)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 75
    Baseline and Post-Treatment Results of Echocardiographic Variables in Each Experimental Group.

    Baseline and Post-Treatment Results of Echocardiographic Variables in Each Experimental Group. by Káryta Suely Macêdo Martins (22404155)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 76
    Illustrative images of the processing of a myocardial perfusion study in a patient with Chagas disease.

    Illustrative images of the processing of a myocardial perfusion study in a patient with Chagas disease. by Káryta Suely Macêdo Martins (22404155)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 77
    Clinical and Demographic Characteristics of the Study Population.

    Clinical and Demographic Characteristics of the Study Population. by Káryta Suely Macêdo Martins (22404155)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 78
    Illustrative images of the quantitative processing of polar maps from a myocardial perfusion study in one of the investigated patients.

    Illustrative images of the quantitative processing of polar maps from a myocardial perfusion study in one of the investigated patients. by Káryta Suely Macêdo Martins (22404155)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 79
    Baseline and Post-Treatment Serum Cytokine Levels in Each Investigational Group.

    Baseline and Post-Treatment Serum Cytokine Levels in Each Investigational Group. by Káryta Suely Macêdo Martins (22404155)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 80
    Baseline and Post-Treatment Serum Levels of NT-proBNP in Each Investigational Group.

    Baseline and Post-Treatment Serum Levels of NT-proBNP in Each Investigational Group. by Káryta Suely Macêdo Martins (22404155)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: